Literature DB >> 3297909

Progressive bile duct injury after thiabendazole administration.

J C Manivel, J R Bloomer, D C Snover.   

Abstract

A 27-yr-old man developed jaundice 2 wk after exposure to thiabendazole. Cholestasis persisted for 3 yr, at which time a liver transplant was performed. Two liver biopsy specimens and the hepatectomy specimen were remarkable for almost complete disappearance of interlobular bile ducts. Prominent fibrosis and hepatocellular regeneration were also present; however, the lobular architecture was preserved. This case represents an example of "idiosyncratic" drug-induced liver damage in which the primary target of injury is the bile duct. An autoimmune pathogenesis of the bile duct destruction is suggested.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3297909     DOI: 10.1016/0016-5085(87)91009-2

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  3 in total

1.  Thiabendazole inhibits ubiquinone reduction activity of mitochondrial respiratory complex II via a water molecule mediated binding feature.

Authors:  Qiangjun Zhou; Yujia Zhai; Jizhong Lou; Man Liu; Xiaoyun Pang; Fei Sun
Journal:  Protein Cell       Date:  2011-08-06       Impact factor: 14.870

2.  Micronodular cirrhosis after thiabendazole.

Authors:  M A Roy; F W Nugent; H T Aretz
Journal:  Dig Dis Sci       Date:  1989-06       Impact factor: 3.199

3.  Bile ductopenia following therapy with sulpiride.

Authors:  D Villari; F Rubino; F Corica; S Spinella; E Di Cesare; G Longo; G Raimondo
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.